Aimmune Therapeutics - 48 Year Dividend History | AIMT
Historical dividend payout and yield for Aimmune Therapeutics (AIMT) since 1971. The current TTM dividend payout for Aimmune Therapeutics (AIMT) as of July 23, 2019 is $0.00. The current dividend yield for Aimmune Therapeutics as of July 23, 2019 is 0.00%.
||Medical - Biomedical and Genetics
Aimmune Therapeutics, Inc. is a biopharmaceutical company which is engaged in the development of desensitization treatments for peanut and other food allergies. The Company's characterized oral desensitization immunotherapy includes AR101, a product for the treatment of peanut allergy in children and adults which is in clinical trial stage. Aimmune Therapeutics, Inc. is headquartered in Brisbane, California.